The Department of Justice (DOJ) announced a $1.67 million settlement with a drug supplier accused of violating federal anti-kickback laws by offering free inventory management systems to retina practices in exchange for purchasing their drugs.
The supplier of an inventory management system used in physicians’ offices has agreed to pay a $1.67 million to settle claims it violated federal anti-kickback laws by providing systems at no costs to retina practices as an incentive to purchase drugs from the supplier., the Department of Justice (DOJ) stated in a press release. ASD and Besse are subsidiaries of Cencora, formerly known as Amerisource Bergen.
ASD distributes specialty drugs nationwide, including biologic injections for treating neovascular, or wet, age-related macular degeneration (AMD). According to the settlement agreement, ASD acquired the PODIS inventory management system in 2017 and through November 2023 gave the system at no cost to physicians if they signed “prime vendor agreements” that obligated them to purchase a set percentage of their specialty drugs from ASD, including branded medications for wet AMD, and for switching to ASD from another inventory management system. The DOJ claimed those activities violated federal laws barring “ any person, including specialty medical and pharmaceutical suppliers, from offering or paying, directly or indirectly, any remuneration — which includes money or anything of value, such as free inventory management systems — to induce the purchase of a drug that Medicare pays for. ” Customers who did not sign the agreements paid a monthly fee for the PODIS system, but once ASD acquired PODIS, the company cut off retina practices that used PODIS but were not ASD customers, even if they offered to pay a monthly fee, according to the DOJ. Medicare spent almost $386 million on branded AMD drugs in 2022, the last year for which data is available. This includes the $334.4 million spent on aflibercept.The case arose from whistleblower claims brought by two former employees of Regeneron Pharmaceuticals, which manufactures and distributes Eylea (aflibercept 2 mg), one of the top-selling treatments for wet AMD, and since FDA approval in 2023, Eylea HD (aflibercept 8 mg). The whistleblowers, Julianne Nunnelly and Matthew Shanks, will receive $250,705 from the proceeds of the settlement, the DOJ stated. The DOJ alleged that the kickbacks induced physicians to submit false claims to Medicare, TRICARE, and the Department of Veterans Affairs. “According to the allegations in today’s settlement, ASD purchased a commercially available product and leveraged it to gain business in violation” of the anti-kickback statutes, said principal deputy assistant attorney general Brian M. Boynton, head of the Justice Department’s Civil Division.Cencora issued a statement that read, “While Besse Medical is confident that we have always acted in accordance with the law, we believe this settlement is the right approach to resolving the matter with the US government and allows us to focus on best meeting the needs of customers and patients. We strongly dispute the idea that there was any wrongful conduct.” After discussions with the government, the company has made improvements to its inventory management contracting processes, the statement read, “and we will continue to regularly monitor and evolve these processes as necessary moving forward.” against Regeneron, alleging the company fraudulently inflated Medicare reimbursement rates for Eylea by submitting false average sales price reports to the Centers for Medicare and Medicaid Services that excluded certain price concessions. That claim remains pending, the DOJ said
ANTIKICKBACK LAWS MEDICARE FRAUD DRUG SUPPLIERS WHISTLEBLOWERS RETINA PRACTICES
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Zayn Malik's Drug Supplier Arrested After Singer's DeathA former hotel worker faces charges for allegedly supplying drugs to the late One Direction singer, Zayn Malik, in the months leading up to his death.
Read more »
Liam Payne Drug Supplier Turns Himself InHotel worker Ezequiel Pereyra surrendered to Argentine police in connection with the death of singer Liam Payne.
Read more »
Major Southern California water supplier approves spending $141.6 million on Delta tunnel projectA major Southern California water supplier approved a motion to help move forward a project that would tunnel water from the Sacramento-San Joaquin Delta to Southern California.
Read more »
Man City reports record revenues in latest financial accounts but profits are downManchester City reported record revenues of 715 million pounds ($903 million) for the 2023-24 fiscal year. Revenues were up by 2.2 million pounds ($2.78 million) on the previous year, but profits were 73.8 million pounds ($93.2 million) - down from 80.4 million pounds ($101.5 million).
Read more »
Rise in Alaska drug overdose deaths triggers increased effort to stop drug traffickingAccording to the Department of Law, as of Dec. 15, officers have seized over 317 pounds of drugs traveling through the airport including over 100 pounds of fentanyl.
Read more »
SF Supervisor Proposes Mass Arrests, 'Drug Jails' for Downtown Drug CrisisSan Francisco Supervisor Matt Dorsey calls for 'mass arrests' of drug users and dealers, aiming for at least 100 daily arrests, and proposes establishing 'drug jails' with medical and clinical interventions. Critics argue this approach is misguided and instead advocates for expanded behavioral health services.
Read more »